Expert consensus of Chinese Association for the Study of Pain on the non-opioid analgesics for chronic musculoskeletal pain

Abstract

Chronic musculoskeletal pain (CMP) is a common occurrence in clinical practice and there are a variety of options for the treatment of it. However, the pharmacological therapy is still considered to be a primary treatment. The recent years have witnessed the emergence of opioid crisis, yet there are no relevant guidelines on how to treat CMP with non-opioid analgesics properly. The Chinese Medical Association for the Study of Pain convened a panel meeting to develop clinical practice consensus for the treatment of CMP with non-opioid analgesics. The purpose of this consensus is to present the application of nonsteroidal anti-inflammatory drugs, serotonin norepinephrine reuptake inhibitors, serotonin and norepinephrine reuptake inhibitors, muscle relaxants, ion channel drugs and topical drugs in CMP.

Preference of Orthopedic Practitioners Toward the Use of Topical Medicine for Musculoskeletal Pain Management in China: A National Survey

“…10,11 Recently, the Chinese Medical Association Pain Society, which regulated the development of treatment guidelines for clinical pain, has been focusing on promoting the treatment of musculoskeletal pain using non-opioid analgesics. 9 Recently, many primary studies and reviews reported on musculoskeletal pain management in Western societies. 7,[10][11][12][13] Considering the anatomical and physiological differences between Asian and Western populations, there were fewer reports on musculoskeletal pain in Asian populations.…”

“…Opioids were no longer recommended in treating musculoskeletal pain due to the increased risk of adverse reactions and treatment interruptions 10,11 . Recently, the Chinese Medical Association Pain Society, which regulated the development of treatment guidelines for clinical pain, has been focusing on promoting the treatment of musculoskeletal pain using non‐opioid analgesics 9 …”

“…There were several treatments for musculoskeletal pain, of which medication was considered a simple and effective basic treatment, and it was important to know how to use it safely and effectively. In recent years, the drug crisis and safety issues arising from over‐reliance on opioids in China and other Western countries had attracted widespread attention and high alert 9 . Opioids were no longer recommended in treating musculoskeletal pain due to the increased risk of adverse reactions and treatment interruptions 10,11 .…”

“…In recent years, the drug crisis and safety issues arising from over‐reliance on opioids in China and other Western countries had attracted widespread attention and high alert. 9 Opioids were no longer recommended in treating musculoskeletal pain due to the increased risk of adverse reactions and treatment interruptions. 10 , 11 Recently, the Chinese Medical Association Pain Society, which regulated the development of treatment guidelines for clinical pain, has been focusing on promoting the treatment of musculoskeletal pain using non‐opioid analgesics.…”

“… 10 , 11 Recently, the Chinese Medical Association Pain Society, which regulated the development of treatment guidelines for clinical pain, has been focusing on promoting the treatment of musculoskeletal pain using non‐opioid analgesics. 9 …”